NHS England has introduced a new target for practices to switch patients from metered dose inhalers (MDIs) to more environmentally friendly alternatives.
The updated voluntary Investment and Impact Fund (IIF) introduces a target for practices to reduce the proportion of pressurised MDIs they prescribe as a percentage of all non-salbutamol inhaler prescriptions issued on or after 1 October to 25% or less of MDIs prescribed by 2023/24.
Dispex is very pleased that we have already highlighted this within our Informatics Section. The information on Aerosol vs Non-aerosol inhalers also looks at profitability and suggests Best Buys.
Dispex members can login and head to our Informatics- Aerosol vs non-aerosol inhalers page to read in full!
